Comparing the Safety and Effectiveness of PCL and PLLA Injections for Nasolabial Fold Correction
Journal of Cosmetic Dermatology · 2025-09 · 24 (9)
DOI: 10.1111/jocd.70414 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 28.08.2025. Verfasst von Kaixuan Hu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Plastic Surgery Department, Quzhou Kecheng Dainiel Plastic Surgery Outpatient, Quzhou City, China. Hauptthemen laut MEDLINE: Polyesters, Nasolabial Fold, Skin Aging, Dermal Fillers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Nasolabial folds (NLF) deepen with age, necessitating aesthetic treatments. Polycaprolactone (PCL) and poly‐ l ‐lactic acid (PLLA) are commonly used fillers. This study compares their safety and efficacy for NLF correction.
Methods
Participants aged 30–60 years were retrospectively reviewed after undergoing NLF correction with PCL ( n = 65) or PLLA ( n = 71) from January 2023 to December 2023. Primary outcomes included changes in the Nasolabial Fold Wrinkle Severity Rating Scale (WSRS) at baseline and 3, 6, and 12 months post‐treatment. Secondary outcomes assessed patient satisfaction via the FACE‐Q scale, Global Aesthetic Improvement Scale (GAIS), and safety profiles including side effects and adverse events.
Results
At 3 months, PCL exhibited significantly greater wrinkle reduction (WSRS score: 3.08 ± 0.37) compared to PLLA (3.27 ± 0.41; p = 0.007). This trend persisted at 6 months (PCL: 2.23 ± 0.61 vs. PLLA: 2.49 ± 0.75; p = 0.03) and 12 months (PCL: 1.92 ± 0.55 vs. PLLA: 2.17 ± 0.61; p = 0.016). PCL also showed higher significant improvement rates on GAIS at 3 and 6 months. Patient satisfaction (FACE‐Q) was higher in the PCL group at both 6 and 12 months ( p < 0.05). Safety profiles were comparable, with no significant differences in injection site reactions or adverse events.
Conclusion
PCL injections demonstrated superior effectiveness in reducing NLF wrinkle severity and achieving higher patient satisfaction compared to PLLA injections over a 12‐month period. Both materials exhibited comparable safety profiles, suggesting the suitability of PCL as a preferable option for NLF correction in cosmetic dermatology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Plastic Surgery Department, Quzhou Kecheng Dainiel Plastic Surgery Outpatient, Quzhou City, China.
- Department of Dermatology, School of Medicine, Rui Jin Hospital, Shanghai Jiao Tong University, Shanghai City, China.
ORCID-Profile: Shanqing Wang
Zitieren
APA
Hu, K., & Wang, S. (2025). Comparing the Safety and Effectiveness of PCL and PLLA Injections for Nasolabial Fold Correction. Journal of Cosmetic Dermatology, 24(9). https://doi.org/10.1111/jocd.70414
Vancouver
Hu K, Wang S. Comparing the Safety and Effectiveness of PCL and PLLA Injections for Nasolabial Fold Correction. Journal of Cosmetic Dermatology. 2025;24(9). doi:10.1111/jocd.70414
BibTeX
@article{Hu2025,
author = {Hu, Kaixuan and Wang, Shanqing},
title = {Comparing the Safety and Effectiveness of PCL and PLLA Injections for Nasolabial Fold Correction},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
volume = {24},
number = {9},
doi = {10.1111/jocd.70414}
}
EUVIMED